Key facts
- PolyModels Hub’s last known valuation is $34.5M (Oct 2025).
- It has raised $10.8M; the latest was Later Stage VC ($9.4M) in Oct 2025.
- Notable investors include Molten Ventures, Marathon Venture Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for PolyModels Hub
- ·The full record, as it builds
Funding rounds
No funding rounds for PolyModels Hub are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PolyModels Hub
Developer of a drug development acceleration platform designed to deliver across all therapeutic modalities. The company's platform helps to find the right development workflow for your pharmaceutical products based on the most advanced library of models and applications, and it also offers modeling services and products to the pharmaceutical industry, thereby helping companies speed up their innovation in developing new drugs.
- Sector
- Information Technology
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 21
- Website
- polymodelshub.com/
- Ownership
- Privately Held (backing)
PolyModels Hub doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PolyModels Hub shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PolyModels Hub in its N-PORT filings yet. We sweep new filings monthly.